Assembly Biosciences, Inc. (ASMB) vs DiaMedica Therapeutics, Inc. (DMAC)
- Assembly Biosciences, Inc. ASMB 20.09 −2.33%
- DiaMedica Therapeutics, Inc. DMAC 7.57 −5.85%
Assembly Biosciences, Inc. and DiaMedica Therapeutics, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and DiaMedica Therapeutics, Inc. are of similar size ($433.6M and $418.8M). DiaMedica Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 19.7×. DiaMedica Therapeutics, Inc. has the higher net margin (0.00% vs −0.06%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Assembly Biosciences, Inc. leads on 7 and DiaMedica Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ASMB | DMAC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (11.75%) | 0.00% | 0.00% |
| Net margin | (0.06%) | 0.00% | 0.00% |
| Free cash flow margin | (51.53%) | 0.00% | 0.00% |
| Return on equity | (0.03%) | (114.62%) | (56.36%) |
| Return on assets | (0.02%) | (98.18%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack